The science behind Arrabina™-P

The scientifically supported fibre ingredient

The fibres as found in Arrabina™-P provide scientifically substantiated health benefits for digestive health, supported by high-quality research.

Greater bacterial diversity

Arrabina™-P promoted greater diversity of beneficial bacteria at a lower dose than inulin in an in-vitro gut simulation study.³ Greater microbiome diversity has been shown to be correlated with certain health benefits.⁵ ⁶ ⁷

Higher propionate production than inulin³

Arrabina™-P promotes the production of short chain fatty acids in the gut, much like other prebiotic fibres. One study demonstrated that Arrabina™-P produces more propionate when compared to inulin.³ Propionate has been associated with improved gut integrity, reduced inflammation, and potential benefits for healthy glucose support and weight management.⁵ ⁸

Learn More

Better tolerability for more fibre intake

In one study, gas production after consuming Arrabina™-P was similar to placebo making it more tolerable than other fibres such as inulin.4 Better tolerability means multiple servings can be taken throughout the day to help meet fibre requirements without the downside of inulin-like prebiotic fibres such as gas, bloating and gastrointestinal upset. Arrabina™-P is gluten-free and low FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols).

Learn More

References
Disclaimer
This web page is intended to provide business-to-business education and information. Its purpose is not intended to communicate to end consumers. Ingredient information is for educational purposes only; specific ingredients are not intended to prevent, treat, mitigate or cure any disease states. This information is not intended to be used in final consumer products and any use or reference of the intellectual property of Givaudan in the final product may only be made with Givaudan’s prior written permission. The information provided may or may not be applicable to, or satisfy, all regulatory requirements for all global regions. Specific regulatory requirements must be evaluated to ensure compliance within the individual countries and regions.
*